tiprankstipranks
Trending News
More News >
bioMerieux (FR:BIM)
:BIM
France Market
Advertisement

bioMerieux (BIM) Technical Analysis

Compare
9 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
bioMerieux’s (BIM) Moving Averages Convergence Divergence (MACD) indicator is -0.68, suggesting bioMerieux is a Sell.
bioMerieux’s (BIM) 20-Day exponential moving average is 108.60, while bioMerieux’s (BIM) share price is €107.9, making it a Sell.
bioMerieux’s (BIM) 50-Day exponential moving average is 110.84, while bioMerieux’s (BIM) share price is €107.9, making it a Sell.

bioMerieux (BIM) Pivot Points

Nov 30, 2025, 02:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
107.70
108.30
108.80
109.40
109.90
110.50
111.00
Fibonacci
108.30
108.72
108.98
109.40
109.82
110.08
110.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

bioMerieux (BIM) Moving Averages

Nov 30, 2025, 02:23 AM
Period
Simple
Exponential
MA5
109.10Sell
108.59Sell
MA10
107.73Buy
108.33Sell
MA20
107.86Buy
108.60Sell
MA50
110.79Sell
110.84Sell
MA100
115.87Sell
113.23Sell
MA200
116.14Sell
113.19Sell
bioMerieux’s (BIM) 10-Day exponential moving average is 108.33, while bioMerieux’s (BIM) share price is €107.9, making it a Sell.
bioMerieux’s (BIM) 100-Day exponential moving average is 113.23, while bioMerieux’s (BIM) share price is €107.9, making it a Sell.
bioMerieux’s (BIM) stock price is €107.9 and bioMerieux’s (BIM) 50-day simple moving average is 110.79, creating a Sell signal.
bioMerieux’s (BIM) stock price is €107.9 and bioMerieux’s (BIM) 100-day simple moving average is 115.87, creating a Sell signal.
bioMerieux’s (BIM) stock price is €107.9 and bioMerieux’s (BIM) 200-day simple moving average is 116.14, creating a Sell signal.

bioMerieux (BIM) Technical Indicators

Nov 30, 2025, 02:23 AM
Name
Value
Implied Action
RSI (14)
45.22
Neutral
STOCH (9,6)
76.28
Neutral
STOCHRSI (14)
76.28
Neutral
MACD (12,26)
-0.68
Sell
ADX (14)
18.00
Buy
Williams %R
-46.15
Buy
CCI (14)
17.86
Neutral
ATR (14)
1.76
-
Ultimate Oscillator
56.03
Neutral
ROC
1.31
Buy
bioMerieux’s (BIM) Relative Strength Index (RSI) is 45.22, creating a Neutral signal.
bioMerieux’s (BIM) Trend Strength Indicator (ADX) is 18.00, creating a Buy signal.
bioMerieux’s (BIM) Commodity Channel Index (CCI) is 17.86, creating a Neutral signal.
bioMerieux’s (BIM) Price Rate of Change (ROC) is 1.31, creating a Buy signal.

FAQ

Is BIM a Buy, Hold, or Sell?
Based on BIM’s technical indicators, BIM is a Sell.
    What is BIM’s RSI (14)?
    BIM’s RSI (14) is 45.22, which suggests BIM is a Neutral.
      What is BIM’s MACD?
      BIM’s MACD is -0.68, which suggests BIM is a Sell.
        What is BIM’s 5-day moving average?
        BIM’s 5-day moving average is 109.10, which suggests BIM is a Sell.
          What is BIM’s 20-day moving average?
          BIM 20-day moving average is 107.86, which suggests BIM is a Buy.
            What is BIM’s 50-day moving average?
            BIM’s 50-day moving average is 110.79, which suggests BIM is a Sell.
              What is BIM’s 200-day moving average?
              BIM’s 200-day moving average is 116.14, which suggests BIM is a Sell.
                What is BIM’s Williams % R (14)?
                BIM’s Williams % R (14) is -46.15, which suggests BIM is a Buy.
                  What is BIM’s CCI (14)?
                  BIM’s CCI (14) is 17.86, which suggests BIM is a Neutral.
                    What is the share price of bioMerieux?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis